FR3138613B1 - Composition cosmétique topique anti-âge comprenant de la flocculosine - Google Patents

Composition cosmétique topique anti-âge comprenant de la flocculosine

Info

Publication number
FR3138613B1
FR3138613B1 FR2208029A FR2208029A FR3138613B1 FR 3138613 B1 FR3138613 B1 FR 3138613B1 FR 2208029 A FR2208029 A FR 2208029A FR 2208029 A FR2208029 A FR 2208029A FR 3138613 B1 FR3138613 B1 FR 3138613B1
Authority
FR
France
Prior art keywords
flocculosin
cosmetic composition
composition containing
topical anti
aging cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2208029A
Other languages
English (en)
Other versions
FR3138613A1 (fr
Inventor
Delefosse Caroline Malhaire
Célnie Blanchard
Geoffroy Tousch
Florent Yvergnaux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe La Biochimie Appliquee SAS
Original Assignee
Societe La Biochimie Appliquee SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe La Biochimie Appliquee SAS filed Critical Societe La Biochimie Appliquee SAS
Priority to FR2208029A priority Critical patent/FR3138613B1/fr
Publication of FR3138613A1 publication Critical patent/FR3138613A1/fr
Application granted granted Critical
Publication of FR3138613B1 publication Critical patent/FR3138613B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

Composition cosmétique anti-âge à usage topique comprenant à titre de principe actif de la flocculosine, le reste de la composition comprenant des composés généralement admissibles dans le domaine cosmétique et plus particulièrement entre 0,05% et 6% en masse d’une solution de 0,8 à 8 g par litre de flocculosine.
FR2208029A 2022-08-02 2022-08-02 Composition cosmétique topique anti-âge comprenant de la flocculosine Active FR3138613B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR2208029A FR3138613B1 (fr) 2022-08-02 2022-08-02 Composition cosmétique topique anti-âge comprenant de la flocculosine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2208029 2022-08-02
FR2208029A FR3138613B1 (fr) 2022-08-02 2022-08-02 Composition cosmétique topique anti-âge comprenant de la flocculosine

Publications (2)

Publication Number Publication Date
FR3138613A1 FR3138613A1 (fr) 2024-02-09
FR3138613B1 true FR3138613B1 (fr) 2025-10-24

Family

ID=84331044

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2208029A Active FR3138613B1 (fr) 2022-08-02 2022-08-02 Composition cosmétique topique anti-âge comprenant de la flocculosine

Country Status (1)

Country Link
FR (1) FR3138613B1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1541580B1 (fr) 2002-07-10 2013-02-27 Seikagaku Corporation Inhibiteurs de sulfotransférase
WO2004007514A1 (fr) * 2002-07-16 2004-01-22 UNIVERSITé LAVAL Molecule antimicrobienne
WO2009129525A2 (fr) 2008-04-18 2009-10-22 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Cellobio-oligosaccharides antifongiques et anti-carie produits par la dextransucrase
JP6521210B2 (ja) * 2013-05-31 2019-05-29 東洋紡株式会社 セロビオースリピッドを含有することを特徴とするコラーゲン産生促進剤
WO2014192682A1 (fr) * 2013-05-31 2014-12-04 東洋紡株式会社 Agent d'activation contenant un cellobiose lipide en tant qu'ingrédient actif et agent favorisant la production de collagène
CN109350562B (zh) * 2018-12-18 2021-05-25 广州艾蓓生物科技有限公司 一种具有抗污染功效的润唇膏
FR3113236B1 (fr) * 2020-08-05 2024-10-04 Algues Et Mer Fraction purifiée de fucoïdanes pour la préparation de compositions cosmétiques et/ou dermatologiques anti-age.

Also Published As

Publication number Publication date
FR3138613A1 (fr) 2024-02-09

Similar Documents

Publication Publication Date Title
MA56883B1 (fr) Dérivés de 2-hydroxycycloalcane-1-carbamoyle
MA34474B1 (fr) Agonistes de gpr40
WO2019035863A8 (fr) Activateurs de la pyruvate kinase destinés à être utilisés dans le traitement de troubles hématologiques
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
EA200970841A1 (ru) Фармацевтическое применение замещенных амидов
MA47301B1 (fr) Inhibiteurs sélectifs de jak1
TN2009000428A1 (fr) Derives de sulfonylamides destines au traitement d'une croissance cellulaire anormale
ECSP078023A (es) Ingrediente farmacéutico activo en base a canabinoide
SV2010003706A (es) 2,6-diamino-pirimidin-5-il-carboxamidas como inhibidores de syk o jak quinasas
MA35749B1 (fr) Dérivés nucléosidiques 4'-azido, 3'-fluoro substitués en tant qu'inhibiteurs de la réplication de l'arn du vhc
EA201170289A1 (ru) Фармацевтические композиции и способы их получения при низкой концентрации примесей
BRPI0920355B8 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
TR199700878T1 (xx) Monamin oksidaz B inhibit�rleri i�eren farmakotik kompozisyonlar.
MXPA05002651A (es) Composicion oralmente administrable para mejorar la calidad del cabello y del pelo.
BR0311327A (pt) Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo
WO2024108155A3 (fr) Composés, compositions et méthodes
MA32061B1 (fr) Triazolopyridazines en tant qu'inhibiteurs de par1, production de celles-ci, et utilisation en tant que médicaments
FR3138613B1 (fr) Composition cosmétique topique anti-âge comprenant de la flocculosine
CO2022003583A2 (es) Compuestos de curcumina y aminoácidos básicos
MA37880A1 (fr) Formulation transdermique contenant des inhibiteurs de cox
CL2004001843A1 (es) Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax
EA200400707A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
MA27670A1 (fr) Composition pharmaceutique contenant de l'acide 5-methyl-2-2'-(chloro-6'-fluoroanilino)phenylacetique
MX9205236A (es) Amino-propanos sustituidos, procedimientos para su preparacion y su utilizacion.
AR023219A1 (es) Combinacion de inhibidor(es) de no-sintasa y antioxidante(s) metabolico(s)

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20240209

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4